![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jian Jiang, Jarno EJ Wolters, Simone G van Breda, Jos C Kleinjans & Theo M de Kok. (2015) Development of novel tools for the in vitro investigation of drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 11:10, pages 1523-1537.
Read now
Read now
Zhijun Wang, Chunyan Xu, Feng Yu, Lin Tang & Jianhua He. (2011) Predicting cell adhesion receptors using protein sequence index. Open Access Bioinformatics 3, pages 97-105.
Read now
Read now
Svetlana Bureeva & Yuri Nikolsky. (2011) Quantitative knowledge-based analysis in compound safety assessment. Expert Opinion on Drug Metabolism & Toxicology 7:3, pages 287-298.
Read now
Read now
Seema Singh, Naveen Kumar Singhal, Garima Srivastava & Mahendra Pratap Singh. (2010) Omics in mechanistic and predictive toxicology. Toxicology Mechanisms and Methods 20:7, pages 355-362.
Read now
Read now
Melvin
E. Andersen, Mustafa Al-Zoughool, Maxine Croteau, Margit Westphal & Daniel Krewski. (2010) The Future of Toxicity Testing. Journal of Toxicology and Environmental Health, Part B 13:2-4, pages 163-196.
Read now
Read now
James V. Rogers, Jennifer A. Price & James N. McDougal. (2009) A review of transcriptomics in cutaneous chemical exposure. Cutaneous and Ocular Toxicology 28:4, pages 157-170.
Read now
Read now
Peter M Eimon & Amy L Rubinstein. (2009) The use of in vivo zebrafish assays in drug toxicity screening. Expert Opinion on Drug Metabolism & Toxicology 5:4, pages 393-401.
Read now
Read now
Articles from other publishers (44)
Francois Pognan, Mario Beilmann, Harrie C. M. Boonen, Andreas Czich, Gordon Dear, Philip Hewitt, Tomas Mow, Teija Oinonen, Adrian Roth, Thomas Steger-Hartmann, Jean-Pierre Valentin, Freddy Van Goethem, Richard J. Weaver & Peter Newham. (2023) The evolving role of investigative toxicology in the pharmaceutical industry. Nature Reviews Drug Discovery 22:4, pages 317-335.
Crossref
Crossref
Devin Hunt, Megan Branson, Victoria Gifford, Elizabeth Putnam & Mark Pershouse. 2020. Information Resources in Toxicology. Information Resources in Toxicology
453
469
.
Devin Hunt, Megan Branson, Elizabeth Putnam & Mark Pershouse. 2020. Information Resources in Toxicology. Information Resources in Toxicology
415
423
.
Jamal S. M. Sabir, Abdelfatteh El Omri, Noor A. Shaik, Babajan Banaganapalli, Majed A. Al-Shaeri, Naser A. Alkenani, Nahid H. Hajrah, Zuhier A. Awan, Houda Zrelli, Ramu Elango & Muhummadh Khan. (2019) Identification of key regulatory genes connected to NF-κB family of proteins in visceral adipose tissues using gene expression and weighted protein interaction network. PLOS ONE 14:4, pages e0214337.
Crossref
Crossref
Terry R. Van Vleet, Michael J. Liguori, James J. Lynch, III, Mohan Rao & Scott Warder. (2019) Screening Strategies and Methods for Better Off-Target Liability Prediction and Identification of Small-Molecule Pharmaceuticals. SLAS Discovery 24:1, pages 1-24.
Crossref
Crossref
Chongjun ZhaoErwen LiZhaoyi WangJinghuan TianYihang DaiYuanyuan NiFarong LiZhiqiang MaRuichao Lin. (2018)
Nux Vomica
Exposure Triggered Liver Injury and Metabolic Disturbance in Zebrafish Larvae
. Zebrafish 15:6, pages 610-628.
Crossref
Crossref
Abhishek Venkatratnam, John S. House, Kranti Konganti, Connor McKenney, David W. Threadgill, Weihsueh A. Chiu, David L. Aylor, Fred A. Wright & Ivan Rusyn. (2018) Population-based dose–response analysis of liver transcriptional response to trichloroethylene in mouse. Mammalian Genome 29:1-2, pages 168-181.
Crossref
Crossref
Mary T. McBride. 2018. A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment. A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment
177
198
.
Nico Jacobi, Rita Seeboeck, Elisabeth Hofmann, Helmut Schweiger, Veronika Smolinska, Thomas Mohr, Alexandra Boyer, Wolfgang Sommergruber, Peter Lechner, Corina Pichler-Huebschmann, Kamil Önder, Harald Hundsberger, Christoph Wiesner & Andreas Eger. (2017)
Organotypic three-dimensional cancer cell cultures mirror drug responses
in vivo
: lessons learned from the inhibition of EGFR signaling
. Oncotarget 8:64, pages 107423-107440.
Crossref
Crossref
Alison H. Harrill, Jonathan G. Moggs, Karissa K. Adkins, Hellmut G. Augustin, Robert C. Johnson & Michael W. Leach. (2016) A Synopsis of the “Influence of Epigenetics, Genetics, and Immunology” Session Part A at the 35th Annual Society of Toxicologic Pathology Symposium. Toxicologic Pathology 45:1, pages 114-118.
Crossref
Crossref
L. Oyejide, O.R. Mendes & I. Mikaelian. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
407
445
.
Aharon Nachshon, Hanifa J. Abu-Toamih Atamni, Yael Steuerman, Roa'a Sheikh-Hamed, Alexandra Dorman, Richard Mott, Juliane C. Dohm, Hans Lehrach, Marc Sultan, Ron Shamir, Sascha Sauer, Heinz Himmelbauer, Fuad A. Iraqi & Irit Gat-Viks. (2016) Dissecting the Effect of Genetic Variation on the Hepatic Expression of Drug Disposition Genes across the Collaborative Cross Mouse Strains. Frontiers in Genetics 7.
Crossref
Crossref
George D. Loizou. (2016) Animal-Free Chemical Safety Assessment. Frontiers in Pharmacology 7.
Crossref
Crossref
Danielle L. Ippolito, Mohamed Diwan M. AbdulHameed, Gregory J. Tawa, Christine E. Baer, Matthew G. Permenter, Bonna C. McDyre, William E. Dennis, Molly H. Boyle, Cheryl A. Hobbs, Michael A. Streicker, Bobbi S. Snowden, John A. Lewis, Anders Wallqvist & Jonathan D. Stallings. (2016) Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis. Toxicological Sciences 149:1, pages 67-88.
Crossref
Crossref
Polyxeni Tsitou, Marjoke Heneweer & Peter J. Boogaard. (2015) Toxicogenomics in vitro as an alternative tool for safety evaluation of petroleum substances and PAHs with regard to prenatal developmental toxicity. Toxicology in Vitro 29:2, pages 299-307.
Crossref
Crossref
Thierry Rabilloud & Pierre Lescuyer. (2015) Proteomics in mechanistic toxicology: History, concepts, achievements, caveats, and potential. PROTEOMICS 15:5-6, pages 1051-1074.
Crossref
Crossref
Andreas Bender. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
397
412
.
Ginny F. Bao, Philip A. Philip & Asfar S. Azmi. 2014. Molecular Diagnostics and Treatment of Pancreatic Cancer. Molecular Diagnostics and Treatment of Pancreatic Cancer
297
322
.
Alain Sewer, Julia Hoeng, Renée Deehan, Jurjen W. Westra, Florian Martin, Ty M. Thomson, David A. Drubin & Manuel C. Peitsch. 2013. Data Mining in Drug Discovery. Data Mining in Drug Discovery
291
316
.
M.J.A. Jetten, J.C.S. Kleinjans, S.M. Claessen, C. Chesné & J.H.M. van Delft. (2013) Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes. Toxicology in Vitro 27:7, pages 2031-2040.
Crossref
Crossref
Lekan Oyejide, Odete R. Mendes & Igor Mikaelian. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
237
276
.
Enrique Hernández-Lemus. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
163
186
.
Adolf Baumgartner. 2013. Genotoxicity Assessment. Genotoxicity Assessment
245
268
.
Babu A. Manjasetty, Konrad Büssow, Santosh Panjikar & Andrew P. Turnbull. (2011) Current methods in structural proteomics and its applications in biological sciences. 3 Biotech 2:2, pages 89-113.
Crossref
Crossref
Marlon J.A. Jetten, Stan Gaj, Ainhoa Ruiz-Aracama, Theo M. de Kok, Joost H.M. van Delft, Arjen Lommen, Eugene P. van Someren, Danyel G.J. Jennen, Sandra M. Claessen, Ad A.C.M. Peijnenburg, Rob H. Stierum & Jos C.S. Kleinjans. (2012) 'Omics analysis of low dose acetaminophen intake demonstrates novel response pathways in humans. Toxicology and Applied Pharmacology 259:3, pages 320-328.
Crossref
Crossref
Jia Li, Zhong-Wei He & Lan-Qing Ma. 2012. Advances in Electric and Electronics. Advances in Electric and Electronics
223
229
.
Joshua F. Robinson, Jeroen L. A. Pennings & Aldert H. Piersma. 2012. Developmental Toxicology. Developmental Toxicology
347
371
.
Gordon M. Kirby. 2011. Systems Biology and Livestock Science. Systems Biology and Livestock Science
83
108
.
Andrea Seiler, Michael Oelgeschläger, Manfred Liebsch, Ralph Pirow, Christian Riebeling, Tewes Tralau & Andreas Luch. (2011) Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?. Archives of Toxicology 85:11, pages 1361-1372.
Crossref
Crossref
N. LEKIĆ, D. ČERNÝ, A. HOŘÍNEK, Z. PROVAZNÍK, J. MARTÍNEK & H. FARGHALI. (2011) Differential Oxidative Stress Responses to D-Galactosamine-Lipopolysaccharide Hepatotoxicity Based on Real Time PCR Analysis of Selected Oxidant/Antioxidant and Apoptotic Gene Expressions in Rat. Physiological Research, pages 549-558.
Crossref
Crossref
Daniel KrewskiMargit WestphalMustafa Al-ZoughoolMaxine C. CroteauMelvin E. Andersen. (2011) New Directions in Toxicity Testing. Annual Review of Public Health 32:1, pages 161-178.
Crossref
Crossref
Shannon H. O'Shea, John Schwarz, Oksana Kosyk, Pamela K. Ross, Min Jin Ha, Fred A. Wright & Ivan Rusyn. (2011) In Vitro Screening for Population Variability in Chemical Toxicity. Toxicological Sciences 119:2, pages 398-407.
Crossref
Crossref
Anne S. Kienhuis, Jos G.M. Bessems, Jeroen L.A. Pennings, Marja Driessen, Mirjam Luijten, Joost H.M. van Delft, Ad A.C.M. Peijnenburg & Leo T.M. van der Ven. (2011) Application of toxicogenomics in hepatic systems toxicology for risk assessment: Acetaminophen as a case study. Toxicology and Applied Pharmacology 250:2, pages 96-107.
Crossref
Crossref
Stephanie M. Martinez, Blair U. Bradford, Valerie Y. Soldatow, Oksana Kosyk, Amelia Sandot, Rafal Witek, Robert Kaiser, Todd Stewart, Kirsten Amaral, Kimberly Freeman, Chris Black, Edward L. LeCluyse, Stephen S. Ferguson & Ivan Rusyn. (2010) Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity. Toxicology and Applied Pharmacology 249:3, pages 208-216.
Crossref
Crossref
Balam Muñoz & Arnulfo Albores. (2010) The Role of Molecular Biology in the Biomonitoring of Human Exposure to Chemicals. International Journal of Molecular Sciences 11:11, pages 4511-4525.
Crossref
Crossref
Ivan Rusyn & George P. Daston. (2010) Computational Toxicology: Realizing the Promise of the Toxicity Testing in the 21st Century. Environmental Health Perspectives 118:8, pages 1047-1050.
Crossref
Crossref
Céline Narjoz, Philippe Beaune & Isabelle de Waziers. (2010) Idiosyncratiques et « omiques » peuvent-ils rimer ?. médecine/sciences 26:6-7, pages 641-646.
Crossref
Crossref
Laura M. Saba, Paula L. Hoffman, Lawrence E. Hunter & Boris Tabakoff. 2010. Systems Biology in Psychiatric Research. Systems Biology in Psychiatric Research
207
227
.
Yuxia Cui & Richard S Paules. (2010) Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 11:4, pages 573-585.
Crossref
Crossref
Hendrian SukardiChoong Yong UngZhiyuan GongSiew Hong Lam. (2010) Incorporating Zebrafish Omics into Chemical Biology and Toxicology. Zebrafish 7:1, pages 41-52.
Crossref
Crossref
Haruka Momose, Takuo Mizukami, Masaki Ochiai, Isao Hamaguchi & Kazunari Yamaguchi. (2010) A New Method for the Evaluation of Vaccine Safety Based on Comprehensive Gene Expression Analysis. Journal of Biomedicine and Biotechnology 2010, pages 1-7.
Crossref
Crossref
Joseph F. Sina & Frank D. Sistare. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Annette Bakker, Andrea Caricasole, Giovanni Gaviraghi, Giuseppe Pollio, Graeme Robertson, Georg C. Terstappen, Massimiliano Salerno & Patrizia Tunici. (2009) How to Achieve Confidence in Drug Discovery and Development: Managing Risk (from a Reductionist to a Holistic Approach). ChemMedChem 4:6, pages 923-933.
Crossref
Crossref
Irene M. Baskerville-Abraham, Gunnar Boysen, J. Mitchell Troutman, Esra Mutlu, Leonard Collins, Kathryn E. deKrafft, Wenbin Lin, Candice King, Stephen G. Chaney & James A. Swenberg. (2009) Development of an Ultraperformance Liquid Chromatography/Mass Spectrometry Method To Quantify Cisplatin 1,2 Intrastrand Guanine−Guanine Adducts. Chemical Research in Toxicology 22:5, pages 905-912.
Crossref
Crossref